Atherosclerosis and Endothelial Function: Comprehensive Study Notes

Atherosclerosis and Endothelial Function: Comprehensive Notes

  • Overview

    • Atherosclerosis is the leading cause of mortality and morbidity in developing nations; commonly known as the hardening of arteries. The term breaks into “atherosclerosis” and “sclerosis.”
    • It is an inflammatory condition involving lipids, thrombosis, vascular wall elements, and immune cells.
    • Key vessel wall layers:
    • Intima (innermost, facing the lumen) – lined by endothelial cells.
    • Media – composed of smooth muscle cells and elastic fibers.
    • Adventitia (outermost) – contains nerves, lymphatics, blood vessels; carries the vasa vasorum; elastic components aid blood propulsion during systole and diastole.
    • Visual concept: normal vessel vs. atherosclerotic changes (intima/endothelium, media, adventitia) with closer view showing endothelium, elastic wall, intima, media (smooth muscle), and adventitia.

  • Endothelial Cells and Baseline Function

    • Endothelium: thin, flat cells lining the inside of blood vessels; protective barrier.
    • Primary roles:
    • Barrier function to prevent inappropriate blood leakage and clot formation.
    • Regulate blood flow and inflammation.
    • Prevent harmful substances from leaking into the bloodstream.
    • Antithrombotic and vasoregulatory properties include production of substances that prevent clotting and promote vasodilation.
    • Endothelial-derived molecules:
    • Nitric oxide (NO) – vasodilator, inhibits platelet aggregation, fights inflammation; promotes protective, antioxidant gene activation.
    • Heparan sulfate and other factors that contribute to anti-thrombotic properties.
    • Endothelial responses to flow:
    • Laminar flow (straight, unobstructed) favors NO production and protective gene/enzyme activation.
    • Branch points or tortuous flow areas reduce protective NO signaling, increasing vulnerability to plaques.
    • Endothelial function under normal conditions:
    • Impermeable barrier to keep fluid and immune cells properly managed.
    • Anti-inflammatory state with resistance to leukocyte adhesion.
    • Promotes vasodilation and resists thrombosis.

  • Endothelial Activation and Dysfunction

    • Activated endothelium leads to:
    • Increased permeability (leakiness).
    • Increased inflammatory cytokines.
    • Upregulation of leukocyte adhesion molecules, promoting leukocyte sticking/migration into the vessel wall.
    • Balance of vasoactive and thrombogenic factors shifts toward inflammation and potential thrombosis when dysfunctional.
    • Triggers of dysfunction include:
    • Physical stress: high blood pressure (hypertension), increased shear stress.
    • Chemical irritants: smoking, high cholesterol, diabetes.
    • Pathophysiology at branching points:
    • Higher flow at bifurcations can reduce NO protective effects, increasing plaque formation risk.
    • Nitric oxide (NO) role reiterated:
    • NO supports vasodilation, reduces clotting tendency, and combats inflammation; protective when endothelial function is intact.

  • Fatty Streaks, Foam Cells, and Early Plaque

    • Fatty streak: first visible sign of early arterial damage; appears as yellow patches in the intima.
    • Not immediately obstructive; detectable upon inspection of vessels.
    • Foam cells: early immune cell involvement
    • Monocytes migrate into the intima and differentiate into macrophages.
    • Macrophages ingest modified LDL; LDL is the bad cholesterol.
    • Lipid-laden macrophages become foam cells, forming fatty streaks.
    • Lipids and lipoproteins:
    • LDL = low-density lipoprotein (bad cholesterol) – contributes to plaque buildup.
    • HDL = high-density lipoprotein (good cholesterol) – carries cholesterol away to the liver for removal; higher HDL is protective.
    • Triglycerides may also influence risk, often elevated with diabetes and low HDL.
    • Transition to plaque: modified LDL accumulation and macrophage activity lead to lipid core formation and inflammatory milieu.
    • Important concept: LDL is initially useful for cell membranes but becomes harmful when modified and retained in the arterial wall, contributing to plaque development.

  • Smooth Muscle Cells (SMCs), ECM, and Plaque Growth

    • Smooth muscle cells from the media migrate into the intima.
    • SMCs proliferate and synthesize extracellular matrix (ECM) components: collagen, elastin, proteoglycans.
    • This ECM stabilizes the vessel wall but also traps lipids, contributing to plaque growth.
    • SMC contractile function can be lost during the process; shift promotes plaque formation.
    • Proliferation and ECM deposition help form a fibrous cap over the lipid core.
    • The progression pathway: fatty streak → early plaque → lipid core formation → fibrous cap development.

  • Plaque Composition and Vulnerability

    • Core and cap:
    • Soft lipid core (lipid-rich necrotic center) surrounded by a fibrous cap (extracellular matrix of collagen, elastin).
    • The fibrous cap protects the core from exposure to blood, delaying thrombosis.
    • Plaque progression involves enhanced migration of SMCs, altered matrix synthesis and degradation, and lipid core growth.
    • Necrotic core: accumulation of dead cells and lipids within the plaque, contributing to instability.
    • Fibrous cap integrity is critical: thinning of the cap increases rupture risk.
    • When plaques become too large or vessel diameter expands beyond a point, they may rupture, exposing thrombogenic material to blood and triggering thrombus formation.

  • Plaque Rupture, Thrombosis, and Ischemia

    • Rupture of the plaque exposes the lipid core to circulating blood, promoting thrombus formation.
    • Resulting thrombus can acutely block the artery, causing ischemia or infarction depending on the affected territory.
    • Plaque rupture and thrombosis underlie unstable angina, myocardial infarction, and some strokes.
    • Plaques can also rupture at distal sites, with embolization of plaque fragments downstream to smaller arteries.
    • Calcification within plaques increases brittleness, making rupture more likely over time.
    • Microvessels within plaque (vasa vasorum) can bleed and contribute to inflammation and plaque growth.

  • Plaque Complications and Site-Specific Issues

    • Calcification: hardening of plaque; brittle plaques prone to fracture.
    • Ulceration: plaque surface breaks, exposing contents to bloodstream and promoting thrombosis.
    • Bleeding into plaque: intraplaque hemorrhage can enlarge the plaque and narrow the artery further.
    • Embolization: fragments break off and travel downstream to block smaller arteries elsewhere.
    • Weakening of vessel walls: plaque-induced pressure can lead to aneurysm formation and potential rupture.
    • Growth of microvessels (neovascularization) within plaque can lead to fragility and hemorrhage.

  • Clinical Complications and Typical Locations

    • Brain: stroke risk from embolic or thrombotic events.
    • Heart: coronary artery disease can lead to myocardial ischemia, unstable angina, or myocardial infarction.
    • Limbs: peripheral artery disease causing claudication (pain with movement that resolves with rest) or limb ischemia (pain at rest; critical limb ischemia; possible limb loss).
    • Kidneys: atheroembolic renal disease; may occur after procedures like angiography or related to atheroembolism; can lead to renal dysfunction.
    • Abdominal aorta: plaque and calcification increasing rupture risk; aortic rupture is often fatal.

  • Types of Stroke Related to Atherosclerosis

    • Embolic stroke: clot or debris travels from another site (e.g., carotids) to the brain.
    • Thrombotic stroke: clot forms in the brain vessels themselves.
    • Both result in impaired cerebral blood flow and potential brain injury.

  • Peripheral and Renal Vascular Involvement

    • Peripheral artery disease (PAD): reduced blood flow to limbs; claudication; possible critical limb ischemia with rest pain and risk of limb loss.
    • Renal artery disease: renal artery stenosis or atheroembolic renal disease; can be due to atherosclerosis of renal arteries; risk factors include hypertension and diabetes.

  • Risk Factors for Atherosclerosis

    • Nonmodifiable risk factors:
    • Age
    • Male gender
    • Family history of early coronary heart disease (CHD):
      • First-degree male relative with CHD before age 55
      • First-degree female relative with CHD before age 65
    • Modifiable risk factors:
    • Dyslipidemia (abnormal lipids): high LDL, low HDL, high triglycerides; diet rich in saturated fats and fried foods elevates LDL.
    • Smoking
    • Hypertension
    • Diabetes mellitus (often type 2 in this context): associated with dyslipidemia and vascular damage
    • Obesity
    • Physical inactivity
    • Diet and lipids:
    • High LDL is strongly linked to plaque formation and coronary disease risk.
    • HDL helps remove cholesterol from arteries to the liver for excretion; higher HDL lowers risk.
    • Triglycerides, especially with low HDL, can worsen risk, particularly in type 2 diabetes.
    • By contrast, populations with lower saturated fat intake tend to have lower cholesterol and fewer heart problems.

  • Lipoprotein Roles and Inflammation

    • LDL (low-density lipoprotein) is the main cholesterol carrier that contributes to plaque formation when modified and retained in vessel walls.
    • HDL (high-density lipoprotein) promotes reverse cholesterol transport, moving cholesterol away from arteries to the liver for disposal.
    • Inflammation and oxidative stress (reactive oxygen species) promote endothelial damage and plaque progression.
    • Foam cells arise when macrophages ingest modified LDL, turning into lipid-laden cells that contribute to the fatty streak and early plaque.
    • The balance of lipids and inflammatory processes governs plaque stability and progression.

  • Clinical Relevance and Diagnostics

    • Imaging and screening focus on major arterial beds: abdominal aorta, coronary arteries, carotids, renal arteries, and peripheral vessels (e.g., popliteal arteries).
    • Imaging modalities in practice may include echocardiography and carotid ultrasound to assess plaque burden and risk.

  • Key Definitions and Concepts

    • Ischemia: reduced blood flow to tissue, risking tissue viability.
    • Infarct: tissue death due to prolonged ischemia.
    • Stable plaque: thick fibrous cap, small lipid core, more smooth muscle, fewer inflammatory cells; less rupture risk but still lumen-narrowing.
    • Vulnerable (unstable) plaque: thin fibrous cap, large soft lipid core, many inflammatory cells, few smooth muscle; high rupture and thrombosis risk.

  • Sequence of Atherosclerotic Progression (for quick recall)

    • Endothelial dysfunction due to trauma/irritants → fatty streak formation via monocyte-derived foam cells → early plaque with lipid core and smooth muscle migration → fibrous cap formation → plaque growth and possible rupture → thrombosis and downstream ischemia or infarction.
    • Plaque rupture can lead to thrombosis which may culminate in myocardial infarction, stroke, or peripheral ischemia depending on the affected territory.

  • Practical Takeaways for Exam Preparation

    • Remember the three vessel-wall layers and their roles, especially endothelium as a regulator of vascular tone and thrombosis.
    • Distinguish between fatty streak, plaque progression, lipid core, and fibrous cap; understand how each stage contributes to risk.
    • Understand the difference between stable and vulnerable plaques and their clinical implications.
    • Recognize the major sites of atherosclerotic involvement and the typical complications associated with each (brain, heart, kidneys, limbs).
    • Be able to define and differentiate ischemia vs infarct; embolic vs thrombotic stroke.
    • Recall modifiable vs nonmodifiable risk factors and how dyslipidemia contributes to disease progression; know the LDL/HDL roles and the impact of triglycerides in type 2 diabetes.

  • Quick Reference Equations and Concepts (LaTeX)

    • extLDL=extlow−densitylipoproteinext(badcholesterol)ext{LDL}= ext{low-density lipoprotein} ext{ (bad cholesterol)}
    • extHDL=exthigh−densitylipoproteinext(goodcholesterol)ext{HDL}= ext{high-density lipoprotein} ext{ (good cholesterol)}
    • Higher extLDLext{LDL} and lower extHDLext{HDL} increase atherosclerotic risk; higher extHDLext{HDL} reduces risk via reverse cholesterol transport.
    • extIschemia=extreducedbloodflowtotissueext{Ischemia} = ext{reduced blood flow to tissue}; extInfarct=exttissuedeathduetoprolongedischemiaext{Infarct} = ext{tissue death due to prolonged ischemia}
    • Plaque evolution can be conceptually summarized as: fatty streak → early plaque → plaque progression → plaque rupture → thrombus formation.

  • Note on Language from Source

    • The lecture occasionally used terms like “adventa/adventa” and described some molecular details in a lecture-room style; notes preserve the intended meaning while aligning to standard terminology (adventitia; NO for nitric oxide).